Skip to main content

SoftBank spends billions dollars to dominate future industry

SoftBank Group Corp. spent US$100 billion this year or nearly equal to the amount of money injected to venture capital support companies last year. The venture giant based in Tokyo through Vision Fund is aggressively funding startups that are thoroughly projected to dominate the future front of the industry.

Tinuku SoftBank spends billions dollars to dominate future industry

SoftBank founded by Masayoshi Son in 1981 based on planting US$100 billion this year in technology world with venture capital funds in companies. Analysts say Softbank's move will shake up given the technology companies will hold the future of the industry.

CB Insights reported SoftBank last year received US$100.8 billion in 8,372 transactions worldwide. Large amounts of cash will accelerate the trend in which startups grow fast without openness and transparency in the stock market.

Some investors are worried that Vision Fund will buy startups at high prices, discourage other investors and extend the time it takes for startups to go public. SoftBank has set a plan to focus on the final stage of investment at more established startups.

SoftBank has prepared about US$10 billion in cash into Uber Technologies Inc. in Silicon Valley which has a near US$70 billion valuation ahead of its IPO plan in 2019. SoftBank's initial and profitable investment in Alibaba Group Holding Limited is also part of a strategy that focuses on booming e -commerce in China.

Analysts equate Son's investment style with "matchmaking" which targets various segments of technology companies to build mutual help opportunities in the future. The Vision Fund's main objectives include e-commerce, ride-sharing, robotics and machine learning.

SoftBank has shown a preference for technological trends with the potential to spread across boundaries and have a significant impact on people's lives. Ride-sharing, e-commerce and other platforms have a myriad of data for artificial intelligence as an information resource.

The strategy also provides a place for other investors, but can reduce the profits of investors when SoftBank negotiates in a strong position to buy it in the future.


Popular posts

GyroCycle motorcycle self-balancing gyroscope tech by Thrustcycle Enterprises LLC ready market 2017

Tinuku ~ Thrustcycle Enterprises LLC has been set up GyroCycle electric motorcycle that will not collapse even without the support for the production in 2017. The company is based in Honolulu designing electric motorcycles equipped gyroscopic technology for stability and anti-collapse.

Know Various Types of Traditional Indonesian Batik Patterns

Tinuku ~ Various types of batik spread across the archipelago. Batik is art of painting using cloth has a pattern and a special way of making the write or paste on the fabric. By treatment with certain distinctive ways.

Batik is pictorial cloth made specifically by writing or applying wax to cloth and since October 2, 2009 batik has been designated as one of Indonesia's cultural heritage by UNESCO.

Everyone knows batik designs have supernatural powers and each motif worn only by specific users. Parang motif which symbolizes strength and power, should only be worn by rulers and knights. Batik of this type must be made with calmness and patience.

If you do wrong in the batik process, the magical power is lost. The process of making batik is full of philosophical meaning, batik is a meaningful symbols that shows how society thinks maker.

Perhaps you just know only one kind of batik design. But geography and area of Indonesia storing various types of batik motifs depending on region t…

GlaxoSmithKline, Novartis AG and Bill Gates pushing against malaria

GlaxoSmithKline Plc and Novartis AG will donate a research fund of up to US$4 billion in a global effort to fight malaria as a drug-resistant strain has not progressed for years. Commitment is part of a broad initiative led by the Bill & Melinda Gates Foundation with US$1 billion,

Glaxo invested an additional US$250 million, while Novartis will allocate more than US$100 million, the company said before Wednesday's meeting in London. Urgency increases when the case of malaria grows significantly in 2016 for the first time in a decade. The emergence of resistance to drugs and insecticides makes efforts to eradicate the disease more difficult.

Certain variants of the lethal parasite Plasmodium falciparum are able to avoid artemisinin as the most potent drug available today. This resistant strain has been detected in five Asian countries and takes risks in Africa. Philanthropic billionaire Bill Gates has said it would be a "disaster" if the mutant form of the parasite mo…